Extracranial implantable devices, systems and methods for the treatment of medical disorders
The present disclosure relates to methods, devices and systems used for the treatment of medical disorders via stimulation of the superficial elements of the trigeminal nerve. More specifically, minimally invasive systems, devices and methods of stimulation of the superficial branches of the trigeminal nerve located extracranially in the face, namely the supraorbital, supratrochlear, infraorbital, auriculotemporal, zygomaticotemporal, zygomaticoorbital, zygomaticofacial, nasal and mentalis nerves (also referred to collectively as the superficial trigeminal nerve) are disclosed herein.
1. A method for treatment of a medical disorder by trigeminal nerve stimulation, comprising:
implanting an implantable electrode assembly including a first contact and a second contact above a pericranium and below an epidermis at a patient's forehead such that the first contact is in contact with a supraorbital nerve and the second contact is in contact with an adjacent supratrochlear nerve; and
applying electrical signals to the electrode assembly to stimulate the supraorbital nerve and the adjacent supratrochlear nerve at the patient's forehead to modulate a body system of the patient to treat the medical disorder selected from the group consisting of attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).
2. The method of claim 1 , wherein the implanting comprises implanting the implantable electrode assembly including a third contact.
3. The method of claim 1 , wherein the applying of the electrical signals comprises applying electrical signals at a frequency between 20 and 300 Hertz, at a current of 0.1 to 3 milliamperes (mA), and at a pulse duration of less than or equal to 500 microseconds.
4. The method of claim 1 , wherein the applying of the electrical signals comprises applying electrical signals at a frequency between 20 and 300 Hertz, at a pulse duration between 50 and 500 microseconds, at an output current density of not greater than 10 mA/cm 2 , and a charge density of not greater than 10 microCoulomb/cm 2 at the patient's cerebral cortex.
5. The method of claim 1 , wherein the applying of the electrical signals comprises applying electrical signals at an output current density of not greater than 10 mA/cm 2 .
6. The method of claim 1 , wherein the applying of the electrical signals comprises applying electrical signals at an output current density of between 2.5 and 5 mA/cm 2 .
7. The method of claim 1 , wherein the applying of the electrical signals comprises applying electrical signals at an output current density of not greater than 7 mA/cm 2 .
8. The method of claim 1 , wherein the implanting comprises implanting the implantable electrode assembly including a third contact and a fourth contact such that the third contact is in contact with a remaining supraorbital nerve and the fourth contact is in contact with an adjacent remaining supratrochlear nerve, wherein the applying of the electrical signals to the electrode assembly is further to stimulate the remaining supraorbital nerve and the adjacent remaining supratrochlear nerve at the patient's forehead to modulate the body system to treat the medical disorder.